Related Experiment Videos
The subxiphoid approach to pericardial disease
The Annals of Thoracic Surgery
|July 1, 1982
Summary
The subxiphoid pericardial window effectively treats uremic pericarditis and tuberculous pericarditis with chemotherapy. Malignant pericardial disease requires careful pre-operative evaluation for better patient outcomes.
Area of Science:
- Cardiology
- Thoracic Surgery
- Nephrology
Background:
- Pericardial effusions pose diagnostic and therapeutic challenges.
- Uremic, malignant, and tuberculous pericarditis require distinct management strategies.
Purpose of the Study:
- To evaluate the efficacy of the subxiphoid pericardial window procedure.
- To assess its utility in diagnosing and treating various pericardial effusion etiologies.
Main Methods:
- A retrospective analysis of 25 patients undergoing subxiphoid pericardial window.
- Patients were grouped by suspected etiology: uremic pericarditis, malignancy, or diagnostic uncertainty.
Main Results:
- Successful treatment of uremic effusions in 11/12 patients post-dialysis.
- Diagnosis of malignancy confirmed in 6 patients, with 1 long-term survivor.
- 4/7 patients with suspected tuberculous pericarditis achieved asymptomatic status with chemotherapy.
Conclusions:
- Subxiphoid pericardial window is effective for uremic effusions and tuberculous pericarditis management.
- Careful patient selection is crucial for suspected malignant pericardial disease.
- This procedure offers diagnostic and therapeutic benefits across diverse pericardial conditions.